NEW YORK (GenomeWeb News) – MorphoSys raised its financial guidance for 2006, saying new collaborations would bump up revenues to €52 million ($66 million).
 
New collaborations and an extended collabration with Novartis would add €2 million to the expected 2006 revenue of €50 million.
 
The company also expects to lower expenses to €46 million from €49 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.